Back to Case study

A CRM delivered within 12 weeks streamlined sales efforts to exceed sales goals every quarter

 

 

 

A CRM delivered within 12 weeks streamlined sales efforts to exceed sales goals every quarter
A pharmaceutical company developing a novel drug to treat a rare cancer was preparing for the commercial launch of their leading product in the pipeline while awaiting FDA approval. Their sales team needed a solution that allowed for a mobile sales force while managing highly regulated Medical Information Requests from the physicians.

Customer Challenges -

  • Customizing data captured on HCPs and practices.
  • A solution that can be easily scaled as their commercial organization grows.
  • A cost-effective solution that meets their budget restrictions.
  • Easily export data for management reporting.
To learn more about how TikaPharma solved this challenge with its cloud-based, mobile-first solution within 12 weeks, download the case study today.

November 23, 2024

CASE STUDY

Browse other Case Studies

More articles
TikaDevice improved PTA sales by 49% year on year

November 23, 2024

TikaDevice improved PTA sales by 49% year on year

A medical device company became the first company to receive FDA approval for a drug-coated balloon catheter. Sales representatives needed to understand which interventional cardiologists and cardiac.

Read more
Sales increased by 14% in the first year, thanks to TikaDevice

November 23, 2024

Sales increased by 14% in the first year, thanks to TikaDevice

The sales team of 900 was under incredible pressure to understand and stay informed about every individual customer. Representatives had to understand their current inventory, buying habits, contract.

Read more
TIkaNAM supported revenue increase through visibility into contract compliance

November 23, 2024

TIkaNAM supported revenue increase through visibility into contract compliance

Using spreadsheets to manage contracts and pricing hindered the team from operating strategically. Their previous BI software did not provide adequate access to all the important time-critical data.

Read more